Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 25,222 followers.

RT @Sarcoma_papers: Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof…

26 Dec 2022

Reply Repost Favourite

RT @Sarcoma_papers: Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof…

26 Dec 2022

Reply Repost Favourite

RT @DrImranSheikh: Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof…

11 Dec 2022

Reply Repost Favourite

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis https://t.co/wmBhM3DTqD https://t.co/39VpCvQFMO

11 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.